Get started
Author

Maria Chiara Auriemma

Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment
2022 · Maria Rosaria Rizzo, Irene Di Meo, et al. · Pharmacological Research · 178
PDF
Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer’s Disease
2024 · Michele Cerasuolo, Irene Di Meo, et al. · Biomolecules · 45
PDF
Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia
2023 · Michele Cerasuolo, Irene Di Meo, et al. · International Journal of Molecular Sciences · 42
PDF
Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer’s Disease and Aβ Plaque Management
2025 · Michele Cerasuolo, Maria Chiara Auriemma, et al. · International Journal of Molecular Sciences · 17
PDF
In newly diagnosed diabetes, hyperglycemia is associated with increased brain iron deposition, measured by MRI-based Quantitative Susceptibility Mapping (QSM)
2025 · Maria Agnese Pirozzi, Fabrizio Esposito, et al. · Journal of Advanced Research · 8
Common neurodegenerative pathways in brain aging, cognitive decline, type 2 diabetes & metabolic syndrome
2024 · Angela Marie Abbatecola, Beatrice Arosio, et al. · Journal of Gerontology and Geriatrics · 8
PDF
Angiogenic T cells and cognitive function in older adults with type 2 diabetes treated with GLP-1 receptor agonists
2026 · Miriam Longo, Paola Caruso, et al. · Aging Clinical and Experimental Research
Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients
2025 · Alessandro Criscimanna, Jacques Emmanuel Galimard, et al. · Bone Marrow Transplantation
Works count: 8
Citation count: 298
H-index: 6
I10-index: 4
Year
Topic
Type